Literature DB >> 2199283

Animal models of spontaneous diabetic kidney disease.

M T Velasquez1, P L Kimmel, O E Michaelis.   

Abstract

Kidney disease, characterized by proteinuria and glomerular lesions, is a common complication of spontaneous diabetes mellitus in many animal species. It occurs in animals with hypoinsulinemia, hyperinsulinemia, or impaired glucose tolerance. The renal functional and structural abnormalities in spontaneously diabetic animals resemble human diabetic nephropathy in many respects. Mesangial expansion and glomerular basement membrane thickening, two structural hallmarks of diabetic glomerulopathy in humans, are the most frequently encountered lesions in animals. In addition, a nodular form of mesangial expansion that resembles but is not identical with human nodular glomerulosclerosis or the Kimmelstiel-Wilson lesion has been observed in some animal models. Other abnormalities, such as exudative hyaline lesions and arteriolar hyalinosis, have also been noted occasionally in other models. Although diabetic animals may develop kidney disease that resembles human diabetic nephropathy, no single animal model develops renal changes identical to those seen in humans. Nonetheless, animal models with spontaneous diabetic kidney disease may be useful for investigating the mechanisms of development of diabetic nephropathy and the effects of various treatment modalities on the progression of renal disease.

Entities:  

Mesh:

Year:  1990        PMID: 2199283     DOI: 10.1096/fasebj.4.11.2199283

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

Review 1.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

2.  Onset and evolution of nephropathy in rats with spontaneous diabetes mellitus.

Authors:  S M Daniele; S Arriaga; S M Martínez; M C Tarrés; S M Montenegro; A E D'Ottavio; N Hisano; J C Picena; L Morisoli
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

3.  Establishment of a diabetic mouse model with progressive diabetic nephropathy.

Authors:  Akari Inada; Kojiro Nagai; Hidenori Arai; Jun-ichi Miyazaki; Keiko Nomura; Hiroshi Kanamori; Shinya Toyokuni; Yuichiro Yamada; Susan Bonner-Weir; Gordon C Weir; Atsushi Fukatsu; Yutaka Seino
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

5.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Authors:  Y Yamamoto; I Kato; T Doi; H Yonekura; S Ohashi; M Takeuchi; T Watanabe; S Yamagishi; S Sakurai; S Takasawa; H Okamoto; H Yamamoto
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 6.  Modelling diabetic nephropathy in mice.

Authors:  Kengo Azushima; Susan B Gurley; Thomas M Coffman
Journal:  Nat Rev Nephrol       Date:  2017-10-24       Impact factor: 28.314

Review 7.  Use of genetic mouse models in the study of diabetic nephropathy.

Authors:  Terri J Allen; Mark E Cooper; Hui Y Lan
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

8.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 9.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 10.  Use of genetic mouse models in the study of diabetic nephropathy.

Authors:  Terri J Allen; Mark E Cooper; Hui Y Lan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.